COMMON STOCKS—98.4%
|
SHARES
|
VALUE
|
||||||
ARGENTINA—1.5%
|
||||||||
INTERNET & DIRECT MARKETING RETAIL—1.5%
|
||||||||
MercadoLibre, Inc.*
|
325
|
$
|
509,827
|
|||||
(Cost $522,472)
|
||||||||
AUSTRALIA—3.7%
|
||||||||
APPLICATION SOFTWARE—2.3%
|
||||||||
Xero Ltd.*
|
7,450
|
772,955
|
||||||
HEALTHCARE TECHNOLOGY—1.4%
|
||||||||
Pro Medicus Ltd.
|
11,700
|
500,143
|
||||||
TOTAL AUSTRALIA
|
||||||||
(Cost $751,453)
|
1,273,098 | |||||||
CHINA—2.5%
|
||||||||
AUTOMOBILE MANUFACTURERS—2.5%
|
||||||||
BYD Co., Ltd., Cl. H
|
27,400
|
846,908
|
||||||
(Cost $639,069)
|
||||||||
FRANCE—8.6%
|
||||||||
APPAREL ACCESSORIES & LUXURY GOODS—3.0%
|
||||||||
LVMH Moet Hennessy Louis Vuitton SE
|
1,285
|
1,028,814
|
||||||
LIFE SCIENCES TOOLS & SERVICES—2.9%
|
||||||||
Eurofins Scientific SE
|
8,100
|
968,820
|
||||||
RESEARCH & CONSULTING SERVICES—2.7%
|
||||||||
Teleperformance
|
2,175
|
917,370
|
||||||
TOTAL FRANCE
|
||||||||
(Cost $1,469,772)
|
2,915,004
|
|||||||
GERMANY—2.1%
|
||||||||
OIL & GAS REFINING & MARKETING—2.1%
|
||||||||
VERBIO Vereinigte BioEnergie AG
|
13,318
|
721,409
|
||||||
(Cost $645,523)
|
||||||||
HONG KONG—2.3%
|
||||||||
APPAREL ACCESSORIES & LUXURY GOODS—2.3%
|
||||||||
Samsonite International SA*
|
430,483
|
801,273
|
||||||
(Cost $468,119)
|
||||||||
HUNGARY—2.0%
|
||||||||
AIRLINES—2.0%
|
||||||||
Wizz Air Holdings PLC*
|
9,750
|
670,091
|
||||||
(Cost $635,453)
|
||||||||
IRELAND—2.4%
|
||||||||
PACKAGED FOODS & MEATS—2.4%
|
||||||||
Kerry Group PLC, Cl. A
|
5,450
|
807,507
|
||||||
(Cost $642,123)
|
||||||||
ITALY—10.0%
|
||||||||
APPAREL ACCESSORIES & LUXURY GOODS—5.4%
|
||||||||
Moncler SpA
|
15,353
|
1,054,442
|
||||||
PRADA SpA
|
101,500
|
795,342
|
||||||
1,849,784
|
||||||||
AUTOMOBILE MANUFACTURERS—2.7%
|
||||||||
Ferrari NV
|
4,150
|
905,904
|
COMMON STOCKS—98.4% (CONT.)
|
SHARES
|
VALUE
|
||||||
ITALY—10.0% (CONT.)
|
||||||||
DATA PROCESSING & OUTSOURCED SERVICES—1.9%
|
||||||||
Nexi SpA*
|
30,800
|
$
|
659,871
|
|||||
TOTAL ITALY
|
||||||||
(Cost $2,724,850)
|
3,415,559
|
|||||||
JAPAN—7.7%
|
||||||||
ELECTRONIC COMPONENTS—2.1%
|
||||||||
Murata Manufacturing Co., Ltd.
|
8,500
|
705,379
|
||||||
HEALTHCARE SUPPLIES—2.1%
|
||||||||
Hoya Corp.
|
5,100
|
719,965
|
||||||
INDUSTRIAL MACHINERY—2.4%
|
||||||||
FANUC Corp.
|
3,600
|
806,284
|
||||||
SEMICONDUCTOR EQUIPMENT—1.1%
|
||||||||
Lasertec Corp.
|
2,000
|
375,463
|
||||||
TOTAL JAPAN
|
||||||||
(Cost $2,300,547)
|
2,607,091
|
|||||||
NETHERLANDS—6.9%
|
||||||||
DATA PROCESSING & OUTSOURCED SERVICES—2.3%
|
||||||||
Adyen NV*
|
290
|
785,882
|
||||||
HEAVY ELECTRICAL EQUIPMENT—2.8%
|
||||||||
Alfen Beheer BV*
|
9,400
|
947,984
|
||||||
OIL & GAS EQUIPMENT & SERVICES—1.8%
|
||||||||
Core Laboratories NV
|
18,100
|
603,816
|
||||||
TOTAL NETHERLANDS
|
||||||||
(Cost $1,634,875)
|
2,337,682
|
|||||||
NORWAY—1.6%
|
||||||||
ENVIRONMENTAL & FACILITIES SERVICES—1.6%
|
||||||||
Aker Carbon Capture ASA*
|
252,219
|
558,557
|
||||||
(Cost $584,158)
|
||||||||
SPAIN—1.6%
|
||||||||
BIOTECHNOLOGY—1.6%
|
||||||||
Grifols SA#
|
35,997
|
547,514
|
||||||
(Cost $721,008)
|
||||||||
SWITZERLAND—4.4%
|
||||||||
LIFE SCIENCES TOOLS & SERVICES—1.7%
|
||||||||
PolyPeptide Group AG*
|
5,244
|
571,606
|
||||||
SPECIALTY CHEMICALS—2.7%
|
||||||||
Sika AG
|
2,600
|
915,853
|
||||||
TOTAL SWITZERLAND
|
||||||||
(Cost $963,670)
|
1,487,459
|
|||||||
UNITED STATES—41.1%
|
||||||||
APPLICATION SOFTWARE—9.5%
|
||||||||
Adobe, Inc.*
|
1,893
|
1,176,746
|
||||||
Autodesk, Inc.*
|
2,825
|
907,192
|
||||||
Intuit, Inc.
|
2,150
|
1,139,435
|
||||||
3,223,373
|
COMMON STOCKS—98.4% (CONT.)
|
SHARES
|
VALUE
|
||||||
UNITED STATES—41.1% (CONT.)
|
||||||||
COPPER—2.7%
|
||||||||
Freeport-McMoRan, Inc.
|
24,000
|
$
|
914,400
|
|||||
DATA PROCESSING & OUTSOURCED SERVICES—4.2%
|
||||||||
Fiserv, Inc.*
|
4,600
|
529,506
|
||||||
Visa, Inc., Cl. A
|
3,700
|
911,643
|
||||||
1,441,149
|
||||||||
FINANCIAL EXCHANGES & DATA—3.3%
|
||||||||
MSCI, Inc., Cl. A
|
1,900
|
1,132,324
|
||||||
HEALTHCARE EQUIPMENT—2.6%
|
||||||||
Insulet Corp.*
|
3,150
|
881,024
|
||||||
INTERNET & DIRECT MARKETING RETAIL—4.8%
|
||||||||
Amazon.com, Inc.*
|
490
|
1,630,519
|
||||||
OIL & GAS EQUIPMENT & SERVICES—1.9%
|
||||||||
Schlumberger NV
|
21,800
|
628,494
|
||||||
SEMICONDUCTORS—3.4%
|
||||||||
NVIDIA Corp.
|
6,000
|
1,169,940
|
||||||
SYSTEMS SOFTWARE—8.7%
|
||||||||
Crowdstrike Holdings, Inc., Cl. A*
|
3,850
|
976,398
|
||||||
Microsoft Corp.
|
6,900
|
1,965,879
|
||||||
2,942,277
|
||||||||
TOTAL UNITED STATES
|
||||||||
(Cost $9,098,764)
|
13,963,500
|
|||||||
TOTAL COMMON STOCKS
|
||||||||
(Cost $23,801,856)
|
33,462,479
|
|||||||
PREFERRED STOCKS—0.0%
|
SHARES
|
VALUE
|
||||||
UNITED STATES—0.0%
|
||||||||
BIOTECHNOLOGY—0.0%
|
||||||||
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
|
33,858
|
5,079
|
||||||
(Cost $152,361)
|
||||||||
Total Investments
|
||||||||
(Cost $23,954,217)
|
98.4
|
%
|
$
|
33,467,558
|
||||
Affiliated Securities (Cost $152,361)
|
5,079
|
|||||||
Unaffiliated Securities (Cost $23,801,856)
|
33,462,479
|
|||||||
Other Assets in Excess of Liabilities
|
1.6
|
%
|
531,153
|
|||||
NET ASSETS
|
100.0
|
%
|
$
|
33,998,711
|
#
|
American Depositary Receipts.
|
(a)
|
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
|
(b)
|
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 5 - Affiliated Securities.
|
*
|
Non-income producing security.
|
@
|
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified
buyers.
|
Security
|
Acquisition
Date(s)
|
Acquisition
Cost
|
% of net assets
(Acquisition
Date)
|
Market
Value
|
% of net assets
as of
7/31/2021
|
||||||||||||
Prosetta Biosciences, Inc., Series D
|
2/6/15
|
$
|
152,361
|
0.40
|
%
|
$
|
5,079
|
0.01
|
%
|
||||||||
Total
|
$
|
5,079
|
0.01
|
%
|
• |
Level 1 – quoted prices in active markets for identical investments
|
• |
Level 2 – significant other observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
|
• |
Level 3 – significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)
|
Alger Global Focus Fund
|
TOTAL
|
LEVEL 1
|
LEVEL 2
|
LEVEL 3
|
||||||||||||
COMMON STOCKS
|
||||||||||||||||
Consumer Discretionary
|
$
|
7,573,029
|
$
|
3,046,250
|
$
|
4,526,779
|
$
|
—
|
||||||||
Consumer Staples
|
807,507
|
—
|
807,507
|
—
|
||||||||||||
Energy
|
1,953,719
|
1,232,310
|
721,409
|
—
|
||||||||||||
Financials
|
1,132,324
|
1,132,324
|
—
|
—
|
||||||||||||
Healthcare
|
4,189,072
|
1,428,538
|
2,760,534
|
—
|
||||||||||||
Industrials
|
3,900,286
|
—
|
3,900,286
|
—
|
||||||||||||
Information Technology
|
12,076,289
|
8,776,739
|
3,299,550
|
—
|
||||||||||||
Materials
|
1,830,253
|
914,400
|
915,853
|
—
|
||||||||||||
TOTAL COMMON STOCKS
|
$
|
33,462,479
|
$
|
16,530,561
|
$
|
16,931,918
|
$
|
—
|
||||||||
PREFERRED STOCKS
|
||||||||||||||||
Healthcare
|
5,079
|
—
|
—
|
5,079
|
||||||||||||
TOTAL INVESTMENTS IN SECURITIES
|
$
|
33,467,558
|
$
|
16,530,561
|
$
|
16,931,918
|
$
|
5,079
|
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
|
||||
Alger Global Focus Fund
|
Preferred Stocks
|
|||
Opening balance at November 1, 2020
|
$
|
5,079
|
||
Transfers into Level 3
|
—
|
|||
Transfers out of Level 3
|
—
|
|||
Total gains or losses
|
||||
Included in net realized gain (loss) on investments
|
—
|
|||
Included in net change in unrealized appreciation (depreciation) on investments
|
—
|
|||
Purchases and sales
|
||||
Purchases
|
—
|
|||
Sales
|
—
|
|||
Closing balance at July 31, 2021
|
5,079
|
|||
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2021
|
$
|
—
|
Fair Value
July 31, 2021
|
Valuation
Methodology
|
Unobservable
Input
|
Range/Input
|
Weighted
Average Inputs
|
||||||||||
Alger Global Focus Fund
|
||||||||||||||
Preferred Stocks
|
$
|
5,079
|
Income
Approach
|
Discount Rate
|
72.50%-77.50
|
%
|
N/A
|
TOTAL
|
LEVEL 1
|
LEVEL 2
|
LEVEL 3
|
|||||||||||||
Cash, foreign cash and cash equivalents
|
$
|
527,952
|
$
|
527,952
|
$
|
–
|
$
|
–
|
Security
|
Value at
October 31,
2020
|
Purchases/
Conversion
|
Sales/
Conversion
|
Dividend/
Interest
Income
|
Realized
Gain (Loss)
|
Net Change
in
Unrealized
App(Dep)
|
Value at
July 31,
2021
|
|||||||||||||||||||||
Alger Global Focus Fund
|
||||||||||||||||||||||||||||
Preferred Stocks
|
||||||||||||||||||||||||||||
Prosetta Biosciences, Inc., Series D
|
$
|
5,079
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
5,079
|
||||||||||||||
Total
|
$
|
5,079
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
–
|
$
|
5,079
|